Cyprinidae/genética; Cyprinidae/metabolismo; Progesterona/genética; Testículo/metabolismo; Animais; Masculino; Transdução de Sinais/genética; Transdução de Sinais/fisiologia; Testosterona/análogos & derivados; Testosterona/metabolismo

11-KT; 11-ketotestosterone; 3-phosphoinositide dependent protein kinase-1; AKT1; APOE; APP; AR; Androgens; B-cell CLL/lymphoma 6; BCL2-like 1; BCL2L1; BCL6; BMP2; BMP4; CCAAT/enhancer binding protein (C/EBP), alpha; CD40; CD40 molecule, TNF receptor superfamily member 5; CEBPA; CHAT; CPLA2; CTSK; CYP19a; EGFR; EPCAM; ESR; F2RL1; FBJ murine osteosarcoma viral oncogene homolog; FOS; FOS-like antigen 1; FOSL1; FOXO1; Gene set enrichment analysis; HIF1A; HSD11B2; HSD17B1; HSP70; ID2; IGF1; IGF1R; IGF2; IGF2R; IL12B; INS; IRS1; ITGAV; Insulin growth factor; JAK1; JAK2; Janus kinase 1; Janus kinase 2; LOX; MAP2K1; MITF; MMP9; NAMPT; NFKBIA; NOS2; P4; PDPK1; PI3K; PIP3; PLAT; PTGES3B; PTGS2; Phosphatidylinositol (3,4,5)-triphosphate; Phospholipase A2; Progestogens; RAC-α serine/threonine-protein kinase; Runt; SNEA; SP1; STAR; STAT1; STAT3; STAT5A; Sp1 transcription factor; Sub-network enrichment analysis; T; TNFR adaptor protein; TNFRAP; TNFRSF11A; TNFRSF11B; TNFSF11; TNFSF18; Tumor necrosis factor; XPR1; amyloid ß (A4) precursor protein; androgen receptor; apolipoprotein E; bone morphogenetic protein 2; bone morphogenetic protein 4; cathepsin K; choline O-acetyltransferase; coagulation factor II (thrombin) receptor-like 1; cytochrome P450 aromatase; epidermal growth factor receptor; epithelial cell adhesion molecule; estrogen receptor; forkhead box O1; heat shock protein 70; hydroxysteroid (11-ß) dehydrogenase 2; hydroxysteroid (17-ß) dehydrogenase 1; hypoxia inducible factor 1, α subunit (basic helix-loop-helix transcription factor); inhibitor of DNA binding 2; insulin; insulin receptor substrate 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1 receptor; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor 2 receptor; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40); lysyl oxidase; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase); microphthalmia-associated transcription factor; mitogen-activated protein kinase kinase 1; nicotinamide phosphoribosyltransferase; nitric oxide synthase 2, inducible; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; phosphatidylinositol 3-kinase; phosphatidylinositol 3-phosphate; plasminogen activator, tissue; progesterone; prostaglandin E synthase 3; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase); signal transducer and activator of transcription 1, 91kDa; signal transducer and activator of transcription 3 (acute-phase response factor); signal transducer and activator of transcription 5A; steroidogenic acute regulatory protein; sub-network enrichment analysis; testosterone; tumor necrosis factor (ligand) superfamily, member 11; tumor necrosis factor (ligand) superfamily, member 18; tumor necrosis factor receptor superfamily, member 11a, NFKB activator; tumor necrosis factor receptor superfamily, member 11b; xenotropic and polytropic retrovirus receptor 1